NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...
Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeutics, Inc ("Voyager" or the "Company") . Such investors are advised to contact Danielle Peyton at ...
Day One Biopharmaceuticals, Inc. (DAWN) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.64 per share a year ago.
**NM signifies a non meaningful value. A dash signifies the data is not available.
Live Science on MSN6d
Looking Beyond Voyager 1 And 2NASA has explored the space beyond Earth and our solar system with spacecraft like Voyagers 1 and 2, and how we’ve discovered ...
Explore the Tuen Mun neighborhood with the Tuen Mun Voyager, MTR's first light rail sightseeing tour, open on weekends and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback